In vivo and in vitro evaluation of erianin, a novel anti-angiogenic agent
- 1 July 2004
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 40 (10), 1554-1565
- https://doi.org/10.1016/j.ejca.2004.01.041
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Resistance in the anti-angiogenic era: nay-saying or a word of caution?Trends in Molecular Medicine, 2003
- Metabolic responses induced by thrombin in human umbilical vein endothelial cellsBiochemical and Biophysical Research Communications, 2002
- Sphingosine 1-Phosphate Stimulates Cell Migration through a Gi-coupled Cell Surface ReceptorJournal of Biological Chemistry, 1999
- Anti—vascular approaches to solid tumour therapy: Evaluation of vinblastine and flavone acetic acidInternational Journal of Cancer, 1995
- In VitroandIn VivoAntitumoral Phenanthrenes from the Aerial Parts ofDendrobium nobilePlanta Medica, 1995
- Controlling the vasculature: Angiogenesis, anti-angiogenesis and vascular targeting of gene therapyTrends in Pharmacological Sciences, 1995
- Microtubules and microtubule-associated proteinsCurrent Opinion in Cell Biology, 1995
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerizationJournal of Medicinal Chemistry, 1991
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990